Baudry et al. review the main components and operational considerations for running decentralized clinical trials, outline their specific advantages for the cardiovascular field, and propose strategies to mitigate their downsides and ensure their quality.
- Guillaume Baudry
- Prashanth Kulkarni
- Harriette G. C. Van Spall